pta20260113009
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR
Venlo (pta009/13.01.2026/07:05 UTC+1) - Announcement
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Toralf Haag |
| 2 | Reason for the notification | |
| a) | Position/status | Member of the administrative or supervisory body |
| b) | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | QIAGEN N.V. |
| b) | LEI | 54930036WK3GMCN17Z57 |
| 4 | Details of the transaction(s) | |
| a) | Description of the financial instrument, type of instrument | Share |
| Identification code | NL0015002SN0 | |
| b) | Nature of the transaction | Another |
| Following the terms of the synthetic share repurchase by QIAGEN N.V., which was announced in November 2025 and approved in June 2025 at the Annual General Meeting of shareholders, every 20 issued QIAGEN shares were consolidated into 19 QIAGEN shares. The number of shares held by Dr. Haag were consolidated by 219 shares into 4,147 common shares. | ||
| c) | Price(s) | Volume(s) |
| Not Quantifiable | Not Quantifiable | |
| d) | Aggregated price | Aggregated volume |
| Not Quantifiable | Not Quantifiable | |
| e) | Date of the transaction | 07.01.2026 UTC+1 |
| f) | Place of the transaction | Outside a trading venue |
(end)
| Emitter: |
QIAGEN N.V. Hulsterweg 82 5912 PL Venlo Netherlands |
|
|---|---|---|
| Contact Person: | Investor Relations | |
| Phone: | +31 7735566 - 00 | |
| E-Mail: | ir@qiagen.com | |
| Website: | www.qiagen.com | |
| ISIN(s): | NL0015002SN0 (Share) | |
| Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate | |
| Other Stock Exchanges: | NYSE, SIX, BX Swiss |